Patients with chronic rhinosinusitis with nasal polyps saw improvements across all endpoints with tezepelumab, according to an abstract presented here. Results were seen as early as 2 and 4 weeks, ...

Detailed price information for Lyra Therapeutics Inc (LYRA-Q) from The Globe and Mail including charting and trades.

Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected ...

My husband has had an awful runny rose for several months. Our GP prescribed Beconase, but that hasn't worked. What advice do you have? Dr Ellie ...

Medically reviewed by Jurairat J. Molina, MD Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that ...

Positive results from the Tezspire phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps: Cambridge, UK Tuesday, March 4, 2025, ...

which could cause a potentially life-threatening infection, according to the U.S. Food and Drug Administration. Use of any SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System products ...

Phase 3 trials showed significant improvements in nasal polyp size and obstruction. Our government trade tracker caught Pelosi’s 169% AI winner. Discover how to track all 535 Congress member ...

Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.

Mepolizumab is associated with significantly improved outcomes in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) with previous nasal polyps (NP) surgeries, according to research ...

(RTTNews) - The Phase III WAYPOINT trial results revealed that AstraZeneca (AZN.L, AZN) and Amgen's (AMGN) TEZSPIRE (tezepelumab-ekko) significantly decreased nasal polyp severity, reduced the ...

An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first approved for treating asthma in 2021, but new research led by a University ...